LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 8 of 483
Next
>>
>
176 to 200 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Imatinib	0.04	uM	LJP6	2	N18	72	hr	1334	3825	3970	0.9633	0.9447
BT-20	Imatinib	0.04	uM	LJP6	3	N18	72	hr	1334	4315	3970	1.0867	1.1305
BT-20	JNK-9L	0.04	uM	LJP6	1	K24	72	hr	1334	3715	3970	0.9356	0.9029
BT-20	JNK-9L	0.04	uM	LJP6	2	K24	72	hr	1334	3379	3970	0.8509	0.7755
BT-20	JNK-9L	0.04	uM	LJP6	3	K24	72	hr	1334	3469	3970	0.8736	0.8096
BT-20	JW-7-24-1	0.04	uM	LJP6	1	B24	72	hr	1334	3005	3970	0.7568	0.6336
BT-20	JW-7-24-1	0.04	uM	LJP6	2	B24	72	hr	1334	3360	3970	0.8462	0.7683
BT-20	JW-7-24-1	0.04	uM	LJP6	3	B24	72	hr	1334	3286	3970	0.8275	0.7402
BT-20	Lapatinib	0.04	uM	LJP6	1	M24	72	hr	1334	3605	3970	0.9079	0.8612
BT-20	Lapatinib	0.04	uM	LJP6	2	M24	72	hr	1334	3642	3970	0.9172	0.8752
BT-20	Lapatinib	0.04	uM	LJP6	3	M24	72	hr	1334	3694	3970	0.9303	0.8950
BT-20	LDN-193189	0.04	uM	LJP5	1	G06	72	hr	1334	4062	3970	1.0229	1.0346
BT-20	LDN-193189	0.04	uM	LJP5	2	G06	72	hr	1334	4039	3970	1.0171	1.0258
BT-20	LDN-193189	0.04	uM	LJP5	3	G06	72	hr	1334	4325	3970	1.0892	1.1343
BT-20	Linifanib	0.04	uM	LJP6	1	J12	72	hr	1334	4408	3970	1.1101	1.1658
BT-20	Linifanib	0.04	uM	LJP6	2	J12	72	hr	1334	4170	3970	1.0501	1.0755
BT-20	Linifanib	0.04	uM	LJP6	3	J12	72	hr	1334	3991	3970	1.0051	1.0076
BT-20	Linsitinib	0.04	uM	LJP5	1	O24	72	hr	1334	3575	3970	0.9003	0.8498
BT-20	Linsitinib	0.04	uM	LJP5	2	O24	72	hr	1334	3260	3970	0.8210	0.7303
BT-20	Linsitinib	0.04	uM	LJP5	3	O24	72	hr	1334	3551	3970	0.8943	0.8407
BT-20	Mitoxantrone	0.04	uM	LJP5	1	C24	72	hr	1334	1308	3970	0.3294	-0.0101
BT-20	Mitoxantrone	0.04	uM	LJP5	2	C24	72	hr	1334	1636	3970	0.4120	0.1143
BT-20	Mitoxantrone	0.04	uM	LJP5	3	C24	72	hr	1334	1781	3970	0.4485	0.1693
BT-20	Mitoxantrone	0.04	uM	LJP6	1	C24	72	hr	1334	1660	3970	0.4180	0.1234
BT-20	Mitoxantrone	0.04	uM	LJP6	2	C24	72	hr	1334	2348	3970	0.5913	0.3844

|<
<<
Previous
Page 8 of 483
Next
>>
>
176 to 200 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)